Titre:
  • Differences in the use of guideline-recommended therapies among 14 European countries in patients with acute coronary syndromes undergoing PCI.
Auteur:Zeymer, Uwe; James, Stefan; Berkenboom, Guy; Mohacsi, Attila; Iñiguez, Andres; Coufal, Zdeněk; Sartral, Magali; Paget, Marie-Ange; Norrbacka, Kirsi; Ferrieres, Jean; Bakhai, Ameet
Informations sur la publication:European journal of preventive cardiology, 20, 2, page (218-228)
Statut de publication:Publié, 2013-04
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Acute Coronary Syndrome -- mortality -- therapy
Adrenergic beta-Antagonists -- therapeutic use
Aged
Cardiovascular Agents -- therapeutic use
Drug Therapy, Combination
Drug Utilization
Drug Utilization Review
Europe
Female
Guideline Adherence
Healthcare Disparities -- standards
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
Kaplan-Meier Estimate
Male
Middle Aged
Patient Discharge -- standards
Percutaneous Coronary Intervention -- adverse effects -- instrumentation -- mortality -- standards
Physician's Practice Patterns -- standards
Platelet Aggregation Inhibitors -- therapeutic use
Practice Guidelines as Topic
Prospective Studies
Quality Indicators, Health Care -- standards
Registries
Stents -- standards
Time Factors
Treatment Outcome
Note générale:Comparative Study
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:2047-4873
info:doi/10.1177/2047487312437060
info:pii/2047487312437060
info:pmid/22345684